Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes

GP Fadini, E Boscaro, S De Kreutzenberg… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE Reduction of bone marrow–derived circulating progenitor cells has been
proposed as a novel mechanism of cardiovascular disease in type 2 diabetes. The present …
被引用次数：227 相关文章

[引用][C] Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes

G PAOLO FADINI, E BOSCARO… - Diabetes …, 2010 - pascal-francis.inist.fr
Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural
History of Type 2 Diabetes CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes.

GP Fadini, E Boscaro, S De Kreutzenberg… - Diabetes …, 2010 - search.ebscohost.com
OBJECTIVE--Reduction of bone marrow-derived circulating progenitor cells has been
proposed as a novel mechanism of cardiovascular disease in type 2 diabetes. The present …
[HTML] nih.gov

[HTML][HTML] Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes

GP Fadini, E Boscaro, S de Kreutzenberg… - Diabetes …, 2010 - ncbi.nlm.nih.gov
OBJECTIVE Reduction of bone marrow–derived circulating progenitor cells has been
proposed as a novel mechanism of cardiovascular disease in type 2 diabetes. The present …

Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes

GP Fadini, E Boscaro… - Diabetes …, 2010 - search.proquest.com
Reduction of bone marrow-derived circulating progenitor cells has been proposed as a
novel mechanism of cardiovascular disease in type 2 diabetes. The present study was …

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes

GP Fadini, E Boscaro, S de Kreutzenberg… - Diabetes …, 2010 - pubmed.ncbi.nlm.nih.gov
Objective Reduction of bone marrow-derived circulating progenitor cells has been proposed
as a novel mechanism of cardiovascular disease in type 2 diabetes. The present study was …

Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes

GP Fadini, E Boscaro, S de Kreutzenberg, C Agostini… - Diabetes Care, 2010 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> OBJECTIVE</jats: title>< jats: p> Reduction of bone marrow–
derived circulating progenitor cells has been proposed as a novel mechanism of …

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes.

GP Fadini, E Boscaro, S de Kreutzenberg… - Diabetes …, 2010 - europepmc.org
Objective Reduction of bone marrow-derived circulating progenitor cells has been proposed
as a novel mechanism of cardiovascular disease in type 2 diabetes. The present study was …

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes.

G Fadini, E Boscaro… - DIABETES …, 2010 - research.unipd.it
OBJECTIVE: Reduction of bone marrow-derived circulating progenitor cells has been
proposed as a novel mechanism of cardiovascular disease in type 2 diabetes. The present …

[引用][C] Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes

G PAOLO FADINI, E BOSCARO… - Diabetes …, 2010 - American Diabetes Association